Cat. No. | Product name | CAS No. |
DCC4748 |
Sj-bis
Novel selective MDMX antagonist |
|
DCC4749 |
Sjf-0628
Novel BRAF-targeting PROTAC, inducing efficient and potent degradation of mutant BRAF but sparing BRAFWT, inhibiting cell growth in mutant-BRAF driven cancer cells |
2413035-41-1 |
DCC4750 |
Sjf-1521
Novel selective EGFR degrader |
2230821-40-4 |
DCC4751 |
Sjf-1528
Novel potent EGFR degrader, being capable of penetrating the cell membrane, also degrading an exon-20 insertion mutant form of EGFR (ASV duplication) |
2230821-38-0 |
DCC4752 |
Sjg-136
Novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity |
232931-57-6 |
DCC4753 |
Sjp-l-5
Novel inhibitor of HIV-1 infection by blocking viral DNA nuclear entry |
1286237-83-9 |
DCC4754 |
Sk-575
Highly potent and efficacious proteolysis targeting chimera (PROTAC) degrader of PARP1 for treating cancers, potently inhibiting the growth of cancer cells bearing BRCA1/2 mutations and inducing potent and specific degradation of PARP1 in various human ca |
|
DCC4755 |
Skf64346 Hydrochloride
Inhibitor of Aβ self-aggregation |
57664-06-9 |
DCC4756 |
Skf-80723 Hydrobromide
Dopamine D1 receptor agonist |
71636-62-9 |
DCC4757 |
Skf-99101h
Selective, brain penetrant 5-HT(1B/D) receptor agonist |
172378-03-9 |
DCC4758 |
Ski-349
Novel dual-targeted inhibitor of sphingosine kinase and microtubule polymerization |
727686-80-8 |
DCC4759 |
Ski-417616
Potent inhibitor of Dengue viruses (DENV), displaying activities against all four serotypes of DENV, as well as to a related flavivirus, West Nile virus (WNV), and an alphavirus, Sindbis virus (SINV) |
|
DCC4760 |
S-kkwk
Potent influenza A virus (IAV) entry inhibitor, targeting a conserved region of hemagglutinin |
|
DCC4761 |
sklb023
Novel inhibitor of NF |
1266715-49-4 |
DCC4762 |
Sklb028
Millepachine analog, inhibiting tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin |
|
DCC4763 |
Sklb050
Biological Active Reagents |
|
DCC4764 |
Sklb-163
Potent anticancer agent, downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK |
1255099-06-9 |
DCC4765 |
Sklb-329
Novel multikinase inhibitor, potently inhibiting angiogenesis-related kinases including VEGFR1/2/3, and FGFR2, and the Src kinase |
|
DCC4766 |
Sklb-677
Novel FLT3 and Wnt/β-catenin signaling inhibitor, displaying potent activity in models of FLT3-driven AML |
|
DCC4767 |
Sklb70326
Novel inhibitor of cell-cycle progression, inducing G0/G1 phase arrest and apoptosis in human hepatic carcinoma cells |
1257317-77-3 |
DCC4768 |
Skog102
Novel inhibitor of OLIG2 in glioblastoma |
1983927-39-4 |
DCC4769 |
skp Inhibitor C16
Specific Inhibitor of Skp2-Mediated p27 Degradation |
432016-45-0 |